⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL11577139 | 0.91 | — | — | |
| Thiophene SCHEMBL10755217 | 0.80 | — | — | |
| SCHEMBL27525803 | 0.71 | ALDH1A1 (0.35) | — | |
| SCHEMBL27457813 | 0.67 | ALDH1A1 (0.44) | — | |
| SCHEMBL16454 | 0.67 | — | — | |
| SCHEMBL9079795 | 0.67 | — | — | |
| Thiourea SCHEMBL11801759 | 0.65 | — | — | |
| SCHEMBL28297317 | 0.65 | — | — | |
| SCHEMBL5694543 | 0.65 | — | — | |
| SCHEMBL25422685 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366729-A1 | COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA | GENESIS PHARMA SA (GR) | 2024-11-07 | — | — | US | claimed |
| EP-4392033-A1 | COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA | Genesis Pharma SA (GR) | 2024-07-03 | — | — | EP | claimed |
| CN-118284417-A | Combination of a Nurr1 agonist with at least one of an aldosterone antagonist, an insulin modulator and a sulfonylurea | 杰尼西斯制药有限公司 | 2024-07-02 | — | — | CN | claimed |
| WO-2023026247-A1 | COMBINATION OF A NURR1 AGONIST WITH AT LEAST ONE OF AN ALDOSTERONE ANTAGONIST, AN INSULIN MODULATOR AND A SULFONYLUREA | GENESIS PHARMA SA (GR) | 2023-03-02 | — | — | WO | claimed |
| CN-115666617-A | Insulinotropic and glucagon stimulating action of beta-lactoglobulin | 阿尔拉食品公司 | 2023-01-31 | — | — | CN | claimed |
| EP-4061399-A1 | INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN | Arla Foods amba (DK) | 2022-09-28 | — | — | EP | claimed |
| US-20220265776-A1 | COMBINATION | GENESIS PHARMA SA (GR) | 2022-08-25 | — | — | US | claimed |
| EP-3996717-A1 | COMBINATION | Genesis Pharma SA (GR) | 2022-05-18 | — | — | EP | claimed |
| CN-114423461-A | Combination of | 杰尼西斯制药有限公司 | 2022-04-29 | — | — | CN | claimed |
| WO-2021099611-A1 | INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN | ARLA FOODS AMBA (DK) | 2021-05-27 | — | — | WO | claimed |
| WO-2021005147-A1 | COMBINATION | GENESIS PHARMA SA (GR) | 2021-01-14 | — | — | WO | claimed |
| CN-106317348-A | Composite material used for ultrasonic atomizer | 无锡市永亿精密铸造有限公司 | 2017-01-11 | — | — | CN | claimed |
| EP-2475757-B1 | PREVENTION OF BODY ODOUR | HENKEL AG & CO KGAA (DE) | 2016-08-10 | — | — | EP | claimed |
| US-20120164097-A1 | PREVENTION OF BODY ODOUR | HENKEL AG & CO. KGAA (DE) | 2012-06-28 | — | — | US | claimed |
| EP-0073507-B1 | SULFONYL UREAS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-10-16 | — | — | EP | claimed |
| EP-0051465-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-01-16 | — | — | EP | claimed |
| EP-0051465-A1 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-05-12 | — | — | EP | claimed |
| JP-9156213-A | — | — | None | — | — | JP | disclosed |
| US-3998968-A | Benzenesulfonyl ureas and process for their manufacture | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-12-21 | — | — | US | disclosed |
| US-3984416-A | Substituted quinoline-8-carboxamido ethyl benzene-sulfonyl N-cyclopentylmethyl urea | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-10-05 | — | — | US | disclosed |